With that in mind, we focus on developing lasting, well-aligned partnerships with exceptional entrepreneurs and executives to build valuable companies. In addition to capital, we provide deep healthcare domain expertise and an extensive network of industry contacts and resources.

Learn More
February 4, 2014 Lumos Pharma Announces Series A Financing
Read More
November 19, 2013 ChanRx’s Phase 2b Study Of Vanoxerine Shows Strong Safety And Statistically Significant Efficacy Signals For Treatment Of Atrial Fibrillation
Read More